Stay updated on Galegenimab in Geographic Atrophy AMD: Clinical Trial
Sign up to get notified when there's something new on the Galegenimab in Geographic Atrophy AMD: Clinical Trial page.

Latest updates to the Galegenimab in Geographic Atrophy AMD: Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedA new revision tag, Revision: v3.5.4, was added to the page, replacing Revision: v3.5.3. This indicates a newer build/version of the page, with no apparent changes to the study details.SummaryDifference0.0%

- Check23 days agoNo Change Detected
- Check38 days agoChange DetectedThe page’s footer software/version label was updated from “Revision: v3.5.2” to “Revision: v3.5.3.” This represents a release update rather than a change to the study information presented.SummaryDifference0.0%

- Check45 days agoChange DetectedSite revision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check73 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0. No substantive changes to trial details or core content are evident.SummaryDifference0.0%

- Check88 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check109 days agoChange DetectedPage revision tag updated from v3.4.1 to v3.4.2; no substantive content or layout changes are evident. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Galegenimab in Geographic Atrophy AMD: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Galegenimab in Geographic Atrophy AMD: Clinical Trial page.